# US 2023/0389800 A1 · Contactless System and Method for Assessing Tissue Viability and Other Hemodynamic Parameters

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0389800 A1
- Document ID: US20230389800A1
- Status: Published application
- Kind: A1
- Application number: 18/363,802
- Filed: 2023-08-02
- Published: 2023-12-07
- Earliest claimed: 2020-10-28
- Assignees: Vivonics, Inc.
- Applicants: Vivonics, Inc.
- Inventors: Michele Pierro; Kyle Quinn; Alan Woessner
- Web page: https://patentgrep.com/patent/US20230389800A1

## CPC

- A61B 5/0071: {by measuring fluorescence emission}
- A61B 5/02028: {Determining haemodynamic parameters not otherwise provided for, e.g. cardiac contractility or left ventricular ejection fraction}
- A61B 5/0205: Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
- A61B 5/02405: {Determining heart rate variability}
- A61B 5/0261: {using optical means, e.g. infrared light}
- A61B 5/1455: using optical sensors, e.g. spectral photometrical oximeters
- A61B 5/445: {Evaluating skin irritation or skin trauma, e.g. rash, eczema, wound, bed sore}
- A61B 5/7257: {using Fourier transforms}
- A61B 5/14551: {for measuring blood gases}
- A61B 5/14556: {by fluorescence (A61B5/14555 takes precedence)}
- A61B 2560/0223: of calibration, e.g. protocols for calibrating sensors
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

A contactless system for assessing tissue viability and other hemodynamic parameters includes one or more light sources configured to emit lights at a predetermined wavelength sensitive to hemoglobin concentration associated with spontaneous hemodynamic oscillations at tissue in a predetermined area of a human subject. One or more polarizers are each coupled to one or more of the one or more light sources and are configured to polarize the light to a polarized state such that the polarized light in the polarized state diffuses into the tissue in the predetermined area at a predetermined depth and the polarized light is maintained in the polarized state at the predetermined depth. One or more detectors each including a detector polarizer coupled thereto are configured to discriminate the light maintained in the polarized state and at the predetermined depth and are configured to generate a plurality of frames of the tissue in the predetermined area at the predetermined depth. A controller is coupled to the one or more light sources and the one or more detectors. The controller is configured to: acquire the plurality of frames, select a region of interest having the same coordinates for each of the plurality of frames, average the number of pixels within each region of interest to create a raw reference signal, detrend the raw reference signal to create a detrended raw reference signal, perform frequency domain analysis of the detrended raw reference signal, identify a frequency band of interest associated with the spontaneous hemodynamic oscillations, and perform an inverse fast Fourier transform within the frequency band of interest to generate a reference signal indicative of blood volume oscillations at a selected spontaneous hemodynamic oscillation. For each sample of the reference signal at a predetermined point in time, the controller multiplies the sample by each pixel of a frame at the same predetermined point in time to generate a three-dimensional coordinate matrix including a plurality of correlation matrix frames at each predetermined point in time. The controller adds the plurality of correlation matrix frames at each predetermined point in time to generate a two-dimensional hemodynamic map indicative of the strength of the spontaneous hemodynamic oscillation to assess the viability of the tissue in the predetermined area.

## Claims

### Claim 1

A contactless system for assessing tissue viability and other hemodynamic parameters, the system comprising:
one or more light sources configured to emit light at one or more predetermined wavelengths sensitive to concentration of hemoglobin or other chromophores associated with spontaneous hemodynamic oscillations into tissue and/or blood at a predetermined area of a human subject;
one or more polarizers each coupled to one or more of the one or more light sources configured to polarize the light to a polarized state such that the polarized light in the polarized state diffuses into the tissue in the predetermined area at a predetermined depth range and the polarized light is maintained in the polarized state at the predetermined depth range;
one or more detectors each including a detector polarizer coupled thereto configured to discriminate the light maintained in the polarized state and at the predetermined depth range from polarized light reflected from the tissue and/or blood in the predetermined area which has not been maintained in the polarized state and configured to generate a plurality of frames of the tissue in the predetermined area at the predetermined depth; and
a controller coupled to the one or more light sources and the one or more detectors configured to acquire the plurality of frames and configured to detect time-varying changes in the concentration of the hemoglobin or other chromophores resulting from the spontaneous hemodynamic oscillations in the predetermined area using the discriminated light maintained in the polarized state and at the predetermined depth range.

### Claim 2 (depends on 1)

The system of claim 1 in which the controller is configured to generate a two-dimensional hemodynamic map indicative of the strength of the spontaneous hemodynamic oscillation to further assess the viability of the tissue and/or the other hemodynamic parameters.

### Claim 3 (depends on 2)

The system of claim 2 in which the controller is configured to perform one or more or all of the following:
select a region of interest having the same coordinates for each of the plurality of frames;
average the number of pixels within each region of interest to create a raw reference signal;
detrend the raw reference signal to create a detrended raw reference signal;
perform frequency domain analysis of the detrended raw reference signal;
identify a frequency band of interest associated with the spontaneous hemodynamic oscillation;
perform an inverse fast Fourier transform within the frequency band of interest to generate a reference signal including a plurality of samples and indicative of blood volume oscillations at a selected spontaneous hemodynamic oscillation;
for each sample of the reference signal at a predetermined point in time, multiply the sample by each pixel of a frame at the same predetermined point in time to generate a three-dimensional coordinate matrix including a plurality of correlation matrix frames at each predetermined point in time; and
add the plurality of correlation matrix frames at each predetermined point in time to generate a two-dimensional hemodynamic map indicative of the strength of the spontaneous hemodynamic oscillation to assess the viability of the tissue and/or the other hemodynamic parameters in the predetermined area.

### Claim 4 (depends on 1)

The system of claim 1 in which the spontaneous hemodynamic oscillations have a frequency in the range of 0.05 Hz to about 1.5 Hz.

### Claim 5 (depends on 1)

The system of claim 1 in which the predetermined wavelength is in the range of about 500 nm to about 1,000 nm.

### Claim 6 (depends on 1)

The system of claim 1 in which the predetermined depth is in the range of about 0.1 mm to about 0.5 mm.

### Claim 7 (depends on 1)

The system of claim 1 in which the other hemodynamic parameters include at least one of: a heart rate, a resting heart rate, heart rate variability, or tissue and/or blood saturation.

### Claim 8 (depends on 1)

The system of claim 1 in which the one or more detectors include a CCD camera.

### Claim 9 (depends on 1)

The system of claim 1 in which the one or more detectors include a CMOS camera.

### Claim 10 (depends on 1)

The system of claim 1 in which the predetermined area includes a burn area of the human subject.

### Claim 11 (depends on 1)

The system of claim 1 in which the predetermined area includes a wound area of a human subject.

### Claim 12 (depends on 1)

The system of claim 1 further including a light filtering lens coupled to one or more light sources.

### Claim 13

A contactless method for assessing tissue viability and other hemodynamic parameters, the method comprising:
emitting light at one or more predetermined wavelength sensitive to concentration of hemoglobin or other chromophores associated with spontaneous hemodynamic oscillations into tissue and/or blood at a predetermined area of a human subject;
polarizing the light to a polarized state such that the polarized light in the polarized state diffuses into the tissue in the predetermined area at a predetermined depth range and the polarized light is maintained in the polarized state at the polarized depth range;
discriminating the light maintained in the polarized state and at the predetermined depth range from polarized light reflected from the tissue in the predetermined area which has not been maintained in the polarized state and generating a plurality of frames of the tissue in the predetermined area at the predetermined depth range; and
acquiring the plurality of frames to detect time varying changes in the concentration of the hemoglobin or other chromophores resulting from the spontaneous hemodynamic oscillations in the predetermined area using the discriminated light maintained in the polarized state and at the predetermined depth range.

### Claim 14 (depends on 13)

The method of claim 13 further including generating a two-dimensional hemodynamic map indicative of the strength of the spontaneous hemodynamic oscillation to further assess the viability of the tissue and/or the other hemodynamic parameters in the predetermined area.

### Claim 15 (depends on 14)

The method of claim 14 further including performing one or more or all of the following:
acquiring the plurality of frames;
selecting a region of interest having the same coordinates for each of the plurality of frames;
averaging the number of pixels within each region of interest to create a raw reference signal;
detrending the raw reference signal to create a detrended raw reference signal;
performing frequency domain analysis of the detrended raw reference signal;
identifying a frequency band of interest associated with the spontaneous hemodynamic oscillations;
performing an inverse fast Fourier transform within the frequency band of interest to generate a reference signal including a plurality of samples and indicative of blood volume oscillations at a selected spontaneous hemodynamic oscillation;
for each sample of the reference signal at a predetermined point in time, multiplying the sample by each pixel of a frame at the same predetermined point in time to generate a three-dimensional coordinate matrix including a plurality of correlation matrix frames at each predetermined point in time; and/or
adding the plurality of correlation matrix frames at each predetermined point in time to generate a two-dimensional hemodynamic map indicative of the strength of the spontaneous hemodynamic oscillation to assess the viability of the tissue and/or the other hemodynamic parameters in the predetermined area.

### Claim 16 (depends on 13)

The method of claim 13 in which the other hemodynamic parameters include least one of: a heart rate, a resting heart rate, heart rate variability, or tissue saturation.

### Claim 17 (depends on 13)

The method of claim 13 in which the spontaneous hemodynamic oscillations have a frequency in the range of 0.05 Hz to about 1.5 Hz.

### Claim 18 (depends on 13)

The method of claim 13 in which the predetermined wavelength is in the range of about 500 nm to about 1,000 nm.

### Claim 19 (depends on 13)

The method of claim 13 in which the predetermined depth is in the range of about 0.1 mm to about 0.5 mm.

### Claim 20 (depends on 13)

The method of claim 13 in which the predetermined area includes a burn area of the human subject.

### Claim 21 (depends on 13)

The method of claim 13 in which the predetermined area includes a wound area of a human subject.
